Multiple sclerosis (MS) is a demyelinating disorder of the central nervous system which is among the biggest causes of physical disability in young adulthood. It is characterized by demyelinating changes to nerves and inflammation around blood vessels. Though inflammation is often found in patients with MS, anti-inflammatory drugs and immunosuppressants, like low-dose corticosteroids, have not